Read the June 2023 issue of CFTN
The Verifying Accurate Leading-edge IVCT Development (VALID) Act was stripped from the 2022 year-end omnibus spending bill at the last moment, and as of early 2023, the bill’s fate is an open question. FDA regulation of laboratory-developed tests (LDTs)/in vitro clinical tests (IVCTs) would be a significant change for the clinical laboratory industry. Current regulation and the history of FDA oversight of LDTs are discussed.
Legal hemp production soared after the 2018 Agriculture Improvement Act (commonly known as the Farm Bill), and so did interest and production of cannabidiol (CBD). CBD is often used as a starting material to create other, more active, and potentially more profitable compounds, with an increased potential for side reactions and unanticipated byproducts.
The annual conference for Mass Spectrometry & Advances in the Clinical Lab (MSACL) took place in Monterey, CA, from April 2–7, 2023, and brought together experts and professionals from the field of mass spectrometry and clinical laboratory medicine to discuss the latest clinical advancements and current analytical challenges.
Contact the editors with any comments or questions.
